Samuel Agresta

Overview

Samuel Agresta received an average of $1M in total compensation, including $420K in salary, at Foghorn Therapeutics between 2020 and 2021.

Source: SEC filing on April 29, 2022.

Related executives

We found five more executives who work or worked at Foghorn Therapeutics.

Adrian Gottschalk

Foghorn Therapeutics

Chief Executive Officer

Alfonso Quintás-Cardama

Foghorn Therapeutics

Chief Medical Officer

Steven Bellon

Foghorn Therapeutics

Chief Scientific Officer

Allan Reine

Foghorn Therapeutics

Chief Financial Officer

Carl Decicco

Foghorn Therapeutics

Chief Scientific Officer

News

You may also like